BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

799 related articles for article (PubMed ID: 29593044)

  • 1. Control of HIV-1 Pathogenesis in Viremic Nonprogressors Is Independent of Gag-Specific Cytotoxic T Lymphocyte Responses.
    Salgado M; Garcia-Minambres A; Dalmau J; Jiménez-Moyano E; Viciana P; Alejos B; Clotet B; Prado JG; Martinez-Picado J
    J Virol; 2018 Jun; 92(12):. PubMed ID: 29593044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Viral and Cellular Factors Leading to the Loss of CD4 Homeostasis in HIV-1 Viremic Nonprogressors.
    Colomer-Lluch M; Kilpelainen A; Pernas M; Peña R; Ouchi D; Jimenez-Moyano E; Dalmau J; Casado C; López-Galíndez C; Clotet B; Martinez-Picado J; Prado JG
    J Virol; 2022 Jan; 96(1):e0149921. PubMed ID: 34668779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Next-generation sequencing analyses of the emergence and maintenance of mutations in CTL epitopes in HIV controllers with differential viremia control.
    Caetano DG; Côrtes FH; Bello G; Teixeira SLM; Hoagland B; Grinsztejn B; Veloso VG; Guimarães ML; Morgado MG
    Retrovirology; 2018 Sep; 15(1):62. PubMed ID: 30201008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD8+ T Cell Breadth and Ex Vivo Virus Inhibition Capacity Distinguish between Viremic Controllers with and without Protective HLA Class I Alleles.
    Koofhethile CK; Ndhlovu ZM; Thobakgale-Tshabalala C; Prado JG; Ismail N; Mncube Z; Mkhize L; van der Stok M; Yende N; Walker BD; Goulder PJR; Ndung'u T
    J Virol; 2016 Aug; 90(15):6818-6831. PubMed ID: 27194762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two Distinct Mechanisms Leading to Loss of Virological Control in the Rare Group of Antiretroviral Therapy-Naive, Transiently Aviremic Children Living with HIV.
    Vieira VA; Adland E; Grayson NE; Csala A; Richards F; Dacon C; Athavale R; Tsai MH; D'Souza R; Muenchhoff M; Bonsall D; Jooste P; Goulder PJR
    J Virol; 2022 Jan; 96(2):e0153521. PubMed ID: 34757843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delineation of Homeostatic Immune Signatures Defining Viremic Non-progression in HIV-1 Infection.
    Singh AK; Salwe S; Padwal V; Velhal S; Sutar J; Bhowmick S; Mukherjee S; Nagar V; Patil P; Patel V
    Front Immunol; 2020; 11():182. PubMed ID: 32194543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Mutations on Replicative Fitness and Major Histocompatibility Complex Class I Binding Affinity Are Among the Determinants Underlying Cytotoxic-T-Lymphocyte Escape of HIV-1 Gag Epitopes.
    Du Y; Zhang TH; Dai L; Zheng X; Gorin AM; Oishi J; Wu TT; Yoshizawa JM; Li X; Yang OO; Martinez-Maza O; Detels R; Sun R
    mBio; 2017 Nov; 8(6):. PubMed ID: 29184023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of HIV non-progression; robust and sustained CD4+ T-cell proliferative responses to p24 antigen correlate with control of viraemia and lack of disease progression after long-term transfusion-acquired HIV-1 infection.
    Dyer WB; Zaunders JJ; Yuan FF; Wang B; Learmont JC; Geczy AF; Saksena NK; McPhee DA; Gorry PR; Sullivan JS
    Retrovirology; 2008 Dec; 5():112. PubMed ID: 19077215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV Controllers Exhibit Enhanced Frequencies of Major Histocompatibility Complex Class II Tetramer
    Laher F; Ranasinghe S; Porichis F; Mewalal N; Pretorius K; Ismail N; Buus S; Stryhn A; Carrington M; Walker BD; Ndung'u T; Ndhlovu ZM
    J Virol; 2017 Apr; 91(7):. PubMed ID: 28077659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics.
    Klein MR; van Baalen CA; Holwerda AM; Kerkhof Garde SR; Bende RJ; Keet IP; Eeftinck-Schattenkerk JK; Osterhaus AD; Schuitemaker H; Miedema F
    J Exp Med; 1995 Apr; 181(4):1365-72. PubMed ID: 7699324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viremic HIV infected individuals with high CD4 T cells and functional envelope proteins show anti-gp41 antibodies with unique specificity and function.
    Curriu M; Fausther-Bovendo H; Pernas M; Massanella M; Carrillo J; Cabrera C; López-Galíndez C; Clotet B; Debré P; Vieillard V; Blanco J
    PLoS One; 2012; 7(2):e30330. PubMed ID: 22312424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maintenance of viral suppression in HIV-1-infected HLA-B*57+ elite suppressors despite CTL escape mutations.
    Bailey JR; Williams TM; Siliciano RF; Blankson JN
    J Exp Med; 2006 May; 203(5):1357-69. PubMed ID: 16682496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human leukocyte antigen-specific polymorphisms in HIV-1 Gag and their association with viral load in chronic untreated infection.
    Brumme ZL; Tao I; Szeto S; Brumme CJ; Carlson JM; Chan D; Kadie C; Frahm N; Brander C; Walker B; Heckerman D; Harrigan PR
    AIDS; 2008 Jul; 22(11):1277-86. PubMed ID: 18580606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consequences of HLA-B*13-Associated Escape Mutations on HIV-1 Replication and Nef Function.
    Shahid A; Olvera A; Anmole G; Kuang XT; Cotton LA; Plana M; Brander C; Brockman MA; Brumme ZL
    J Virol; 2015 Nov; 89(22):11557-71. PubMed ID: 26355081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-1 evolution in gag and env is highly correlated but exhibits different relationships with viral load and the immune response.
    Piantadosi A; Chohan B; Panteleeff D; Baeten JM; Mandaliya K; Ndinya-Achola JO; Overbaugh J
    AIDS; 2009 Mar; 23(5):579-87. PubMed ID: 19516110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Limited HIV infection of central memory and stem cell memory CD4+ T cells is associated with lack of progression in viremic individuals.
    Klatt NR; Bosinger SE; Peck M; Richert-Spuhler LE; Heigele A; Gile JP; Patel N; Taaffe J; Julg B; Camerini D; Torti C; Martin JN; Deeks SG; Sinclair E; Hecht FM; Lederman MM; Paiardini M; Kirchhoff F; Brenchley JM; Hunt PW; Silvestri G
    PLoS Pathog; 2014 Aug; 10(8):e1004345. PubMed ID: 25167059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pol-Driven Replicative Capacity Impacts Disease Progression in HIV-1 Subtype C Infection.
    Ojwach DBA; MacMillan D; Reddy T; Novitsky V; Brumme ZL; Brockman MA; Ndung'u T; Mann JK
    J Virol; 2018 Oct; 92(19):. PubMed ID: 29997209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A steady state of CD4+ T cell memory maturation and activation is established during primary subtype C HIV-1 infection.
    Maenetje P; Riou C; Casazza JP; Ambrozak D; Hill B; Gray G; Koup RA; de Bruyn G; Gray CM
    J Immunol; 2010 May; 184(9):4926-35. PubMed ID: 20363974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human immunodeficiency virus type 1-specific cytotoxic T lymphocyte activity is inversely correlated with HIV type 1 viral load in HIV type 1-infected long-term survivors.
    Betts MR; Krowka JF; Kepler TB; Davidian M; Christopherson C; Kwok S; Louie L; Eron J; Sheppard H; Frelinger JA
    AIDS Res Hum Retroviruses; 1999 Sep; 15(13):1219-28. PubMed ID: 10480635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gag-positive reservoir cells are susceptible to HIV-specific cytotoxic T lymphocyte mediated clearance in vitro and can be detected in vivo [corrected].
    Graf EH; Pace MJ; Peterson BA; Lynch LJ; Chukwulebe SB; Mexas AM; Shaheen F; Martin JN; Deeks SG; Connors M; Migueles SA; O'Doherty U
    PLoS One; 2013; 8(8):e71879. PubMed ID: 23951263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.